NCT06547359

A Study to Evaluate Drug-Drug Interactions of Obicetrapib Tablets and Ezetimibe Tablets in Healthy Adult Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 94 (actual)
• Sponsor: NewAmsterdam Pharma · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Accepted

Summary

A Study to Evaluate Drug-Drug Interactions of Obicetrapib Tablets and Ezetimibe Tablets in Healthy Adult Subjects

Detailed description

A Study to Evaluate the PK of obicetrapib tablets with and without co-administration of daily doses of ezetimibe tablets and the PK of ezetimibe tablets with and without co-administration of daily doses of obicetrapib tablets.

Conditions

• Healthy Volunteers

Interventions

Type	Name	Description
DRUG	Obicetrapib 10mg	tablets
DRUG	Ezetimibe 10mg	tablets

Timeline

• Start date: 2024-10-01
• Primary completion: 2024-11-12
• Completion: 2024-11-12
• First posted: 2024-08-09
• Last updated: 2024-11-14

Locations

1 site across 1 country: Canada

Regulatory

• FDA-regulated drug study